20 million Americans live with sensory nerve damage affecting their hands and feet.
Peripheral neuropathy increases fall risk by 2.7x, drives $3k-$20k in additional healthcare costs per patient, and yet 80% of neuropathy-related amputations of extremities are preventable with early detection.
The problem?
Clinicians currently lack an affordable, objective, and continuous way to quantitatively track sensory loss over time.
That's where NeuroSense comes in.
We are building a portable medical device that quantifies sensory loss using controlled vibrations, allowing clinicians and patients to measure minimum sensation detection and monitor progression.
By turning sensation into measurable data, we aim to enable earlier detection, better monitoring, and improved patient outcomes for those experiencing peripheral neuropathy.
If you're interested in digital health, neurotechnology, or clinical innovation, let's connect.
#DigitalHealth #PeripheralNeuropathy #HealthcareInnovation #USC #Startup #Medtech
Congrats on the series A, boss man.